Skip to main content

Table 3 Studies utilizing oligonucleotide microarray technology to study asthma

From: Application of microarray technology in pulmonary diseases

Investigator

Microarray type

Species/Sample size

Summary/Key findings

Normalization procedure

 

Number of genes

Type of tissue

 

Replications per data point

Lee et al.34

Oligonucleotide 6.500 genes

Human airway cells

IL-13 induces dramatically different transcriptional programs in three human airway cell types.

Gene expression levels normalized by a scaling factor multiplied to the average of differences of probe pairs (matched-mismatched)/ 1 replicate

Temple et al.35

Oligonucleotide 6800 genes

Human eosinophils

Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes.

Geometric mean of the scaling (standard experiment) factor served as normalization factor/ 2 replicates

Hakonarson et al.36

Oligonucleotide 5.000 genes

Rabbit and human ASM

Association between IL-1beta/TNF-alpha-induced glucocorticoid-sensitive changes in multiple gene expression and altered responsiveness in ASM.

Gene expression levels normalized by a scaling factor multiplied to the average of differences of probe pairs (matched-mismatched) / 2 replicates

Laprise et al.37

Oligonucleotide 12.000 probe sets

8 subjects Lung tissue samples

Functional classes of bronchial mucosa genes that are differentially expressed in asthma.

Mean hybridization intensities of all probe sets on each array were scaled to a fixed level/ 2 replicates

Nakajima et al.39

Oligonucleotide 12.000 genes

Human MCs and eosinophils

Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of MBP in MCs

Mean hybridization intensities of all probe sets on each array were scaled to an arbitrary, fixed level / 1 replicate

  1. Abbreviations: ASM: Airway Smooth Muscle cells, MBP: Major Basic Protein, MCs: Mast cells, TNF: Tumor Necrosis Factor